Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.
Clinical trial NCT04915248 · RECRUITING
Trial details
- NCT number
- NCT04915248
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-11
- Primary completion
- 2027-07-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.